Akkermansia muciniphila protects against dopamine neurotoxicity by modulating butyrate to inhibit microglia-mediated neuroinflammation
International Immunopharmacology · 2025-04 · 152 · 114374
DOI: 10.1016/j.intimp.2025.114374 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2025-04. Verfasst von Kaifei Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education a…. Hauptthemen laut MEDLINE: Butyrates, Microglia, Dopaminergic Neurons, Neuroinflammatory Diseases. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Ministry of Education of the People's Republic of China, Science and Technology Program of Guizhou Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Parkinson's disease (PD) is an age-related and second most common neurodegenerative disease. To date, safe and efficient therapeutic drugs are deficient. In recent years, the relationship between gut microbiota and CNS have received more attention. Homeostatic imbalance of gut microbiota was revealed to participate in the progression of PD. This study detected that Akkermansia muciniphila (A. muciniphila) was apparently decreased in the feces of PD rats via 16S rRNA amplicon sequencing. Furtherly, we found that exogenous supplementation of A. muciniphila could improve 6-OHDA-induced motor dysfunction and dopamine (DA) neuronal damage and neuroinflammatory factors release in PD rats. Moreover, the short-chain fatty acids (SCFAs) sequencing demonstrated that A. muciniphila addition increased butyrate content both in gut and brain. The subsequent functional experiments confirmed that the exogenous supplementation of butyrate conferred neuroprotection against DA neurotoxicity. Mechanically, butyrate targeted microglia to attenuate DA neuronal injury via inhibiting microglia activation and neuroinflammatory factors production. In conclusion, A. muciniphila protected DA neuronal damage by modulating butyrate to inhibit microglia-elicited neuroinflammation. These findings provided a potential application of A. muciniphila on PD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education and Key Laboratory of Basic Pharmacology of Guizhou Province and Labora…
Förderung
- Ministry of Education of the People's Republic of China
- Science and Technology Program of Guizhou Province
- National Natural Science Foundation of China
- Guizhou Provincial Science and Technology Department
Zitieren
APA
Xu, K., Wang, G., Gong, J., Yang, X., Cheng, Y., Li, D., Sheng, S., & Zhang, F. (2025). Akkermansia muciniphila protects against dopamine neurotoxicity by modulating butyrate to inhibit microglia-mediated neuroinflammation. International Immunopharmacology, 152, 114374. https://doi.org/10.1016/j.intimp.2025.114374
Vancouver
Xu K, Wang G, Gong J, Yang X, Cheng Y, Li D, et al. Akkermansia muciniphila protects against dopamine neurotoxicity by modulating butyrate to inhibit microglia-mediated neuroinflammation. International Immunopharmacology. 2025;152:114374. doi:10.1016/j.intimp.2025.114374
BibTeX
@article{Xu2025,
author = {Xu, Kaifei and Wang, Guoqing and Gong, Jiantao and Yang, Xinxing and Cheng, Yufeng and Li, Daidi and Sheng, Shuo and Zhang, Feng},
title = {Akkermansia muciniphila protects against dopamine neurotoxicity by modulating butyrate to inhibit microglia-mediated neuroinflammation},
journal = {International Immunopharmacology},
year = {2025},
volume = {152},
pages = {114374},
doi = {10.1016/j.intimp.2025.114374}
}
EUVIMED